Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
Abstract Severe cytokine release syndrome (CRS) and neurotoxicity following chimeric antigen receptor T cell (CAR-T) therapy can be life-threatening in some cases, and management of those toxicities is still a great challenge for physicians. Researchers hope to understand the pathophysiology of CRS...
| Published in: | Biomarker Research |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-01-01
|
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s40364-018-0116-0 |
